retatrutide for obesity vs Tirzepatide vs Semaglutide Retatrutide—A Game Changer in Obesity

Liji Thomas Dr

Endocrinology 149:574579 Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H, Jacobsen SD, Moses AC, Molck AM, Nielsen HS, Nowak J, Solberg H, Thi TD, Zdravkovic M, Moerch U (2010) Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation

Research is still underway as doctors figure out how long someone should stay on the drug and what dose works best for each individual

Lower-cost medication alternatives: When Medicaid does not cover weight loss shots, providers can consider covered alternatives such as phentermine, orlistat, or naltrexone/bupropion, which may be on the state formulary even when GLP-1s are excluded